TIA Secondary Prevention — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Dual antiplatelet therapy for 21 days then single agent
For minor ischemic stroke or high-risk TIA without cardioembolism, early dual antiplatelet therapy (aspirin + clopidogrel) for 21 days reduces early recurrence, then transition to a single agent. Monotherapy alone is inferior early; anticoagulation is not indicated without AF or another cardioembolic source; deferring therapy is unsafe.
Reference: AHA/ASA Guideline (2021): Stroke Prevention in Patients With Stroke and TIA